Nexstim Plc Industries
-
Clinical Services
-
-
-
-
-
At Nexstim we are using decades of scientific research to help alleviate drug-resistant brain diseases and disorders. As the world’s leading company combining TMS with 3D brain imaging, we offer a powerful noninvasive technique for the relief of chronic, refractory neuropathic pain.
Transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique where pulses of electromagnetic fields target and interact with specific brain regions. As a non-invasive method, TMS is not associated with the side effects commonly caused by anti-depressants.
Nexstim SmartFocus® nTMS mapping offers you the chance to improve outcomes and your patients’ quality of life. The clinical value of using the NBS System with SmartFocus® e-field navigated TMS technology has been firmly established, with over 100 papers on over 4,100 patients published (2020).
For patients undergoing radiotherapy for brain metastases, it is important to preserve quality of life after a course of therapy. As a non-invasive method, SmartFocus® nTMS mapping is a valuable new tool for radiotherapists to accurately and reliably modify dosing to help preserve motor function and potentially the quality of life of their patients.
Our solutions help neurosurgeons plan their most delicate surgeries. NBS accurately and reliably determines the location of vital functions in the brain—such as limb movement, language and speech. As a noninvasive method, NBS mapping can be performed before your treatment decision and prior to any surgery.